From life to death - The struggle between chemistry and biology during aging: The Maillard reaction as an amplifier of genomic damage

Biogerontology

Volumn 1, Issue 3, 2000, Pages 235-246

  Baynes, John W ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Advanced glycation end products; Glycoxidation; Lipoxidation; Maillard reaction; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER;

AGING; ANIMAL; DNA DAMAGE; GENETICS; GENOME; GLYCATION; HUMAN; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

AGING; ANIMALS; BIOLOGICAL MARKERS; DNA DAMAGE; GENOME; HUMANS; MAILLARD REACTION; OXIDATIVE STRESS;

EID: 0034571077     PISSN: 13895729     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010034213093     Document Type: Review

References (76)

1. ∈-(carboxyethyl)lysine, a product of chemical modification of protein by methylglyoxal, increases with age in human lens proteins. Biochem J 324: 565-570
2. Bailey AJ, Paul RG and Knott L (1998) Mechanisms of maturation and ageing of collagen. Mech Ageing Dev 106: 1-56
3. Baynes JW (1991) The role of oxidative stress in the development of complications in diabetes. Diabetes 40: 405-412
4. Baynes JW and Thorpe SR (1999a) The role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9
5. Baynes JW and Thorpe SR (1999b) Glycation and advanced glycation reactions. In: Turtle JR, Kaneko T and Osato S (eds) Diabetes in the New Millennium, pp 337-350. Endocrinology and Diabetes Research Foundation, University of Sydney
6. Bjorksten J (1968) The crosslinkage theory of aging. J Am Geriatr Soc 16: 408-427
7. Brinkmann Frye E, Degenhardt TP, Thorpe SR et al. (1998) Role of the Maillard reaction in aging of tissue proteins: age-dependent increase in imidazolium crosslinks in human lens protein. J Biol Chem 273: 18714-18719
8. Brownlee M, Vlassara H, Kooney A et al. (1986) Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking. Science 232: 1629-1632
9. ∈-(carboxymethyl)lysine and pentosidine, in rat skin collagen. J Gerontol 50A: B337-B441
10. Chellan P and Nagaraj RH (1999) Protein crosslinking by the Maillard reaction; dicarbonyl-derived imidazolium crosslinks in aging and diabetes. Arch Biochem Biophys 368: 98-104
11. Corman B, Duriez M, Poitevin P et al. (1998) Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci USA 95: 1301-1306
12. Degenhardt TP, Alderson NL, Thorpe SR et al. (1998) Pyridoxamine, a post-Amadori inhibitor of advanced glycation reactions, preserves renal function in diabetic rats. J Am Soc Nephrol 9 (Suppl 1): 628a
13. Dyer DG, Blackledge JA, Thorpe SR et al. (1991) Formation of pentosidine during nonenzymatic browning of proteins by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 266: 11654-11660
14. Dyer DG, Dunn JA, Thorpe SR et al. (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91: 2463-2469
15. Fu MX, Wells-Knecht KJ, Blackledge JA et al. (1994) Glycation, glycoxidation and crosslinking of collagen by glucose: kinetics, mechanisms and inhibition of late stages of the Maillard reaction. Diabetes 43: 676-683
16. ∈-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271: 9982-9986
17. Fujii N, Momose Y, Ishii N et al. (1999) The mechanisms of simultaneous stereoinversion, racemization, and isomerization at specific aspartyl residues of aged lens proteins. Mech Ageing Dev 107: 347-358
18. Fujisawa H, Nishikawa T, Zhu B-H et al. (1999) Aminoguanidine supplementation delays the onset of senescence in vitro in dermal fibroblast-like cells from senescence-accelerated mice. J Gerontol 54A: B276-B282
19. Golubev AG (1996) The other side of metabolism. Biokhimiia 61: 2018-2039
20. Harding JJ, Beswick HT, Ajiboye R et al. (1989) Non-enzymic post-translational modification of proteins in aging: a review. Mech Ageing Dev 50: 7-16
21. Harman D (1992) Free radical theory of aging: history. EXS 62: 1-10
22. Hayase F, Nagaraj RH, Miyata S et al. (1989) Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 264: 3758-3764
23. Heinecke JW (1999) Mass spectrometric quantification of amino acid oxidation product in proteins: insights into pathways that promote LDL oxidation in the human artery wall. FASEB J 13: 1113-1120
24. Hoenders HJ and Bloemendal H (1983) Lens proteins and aging. J Gerontol 38: 278-286
25. Hood BD, Garner B and Truscott RJW (1999) Human lens coloration and aging: evidence for crystallin modification by the major ultraviolet filter, 3-hydroxy-kynurenine-O-β-D-glucoside. J Biol Chem 274: 32547-32550
26. ∈-(hexanoyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 274: 20406-20410
27. Lee C, Yim MB, Chock PB et al. (1998) Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation. J Biol Chem 273: 25272-25278
28. Lee AT, Reis D and Eriksson UJ (1999) Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo. Diabetes 48: 371-376
29. Leeuwenburgh C, Rasmussen JE, Hsu FF et al. (1997) Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 272: 3520-3526
30. Leinonen J, Lehtimaki T, Toyokuni S et al. (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417: 150-152
31. Li ML, Steffes M, Donnelley T et al. (1996) Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci USA 93: 3902-3907
32. α-acetyl-lysine, and bovine serum albumin. J Biol Chem 269: 32299-32305
33. Lovaas E and Carlin G (1991) Spermine: an anti-oxidant and antiinflammatory agent. Free Radic Biol Med 11: 455-461
34. Miyata T, Inagi R, Asahi K et al. (1998) Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid an polyunsaturated fatty acids. FEBS Lett 437: 24-28
35. Nakamura K, Nakazawa Y and Ienaga K (1997) Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 232: 227-230
36. Nilsson BO (1999) Biological effects of aminoguanidine: an update. Inflamm Res 48: 509-515
37. Niwa T, Katsuzaki T, Miyazaki S et al. (1997) Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest 99: 1272-1280
38. Obayashi H, Nakano K, Shigeta H et al. (1996) Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo. Biochem Biophys Res Commun 226: 37-41
39. Owen WF Jr, Hou FF, Stuart RO et al. (1998) Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. Kidney Int 53: 1365-1373
40. Oya T, Hattori N, Mizuno Y et al. (1999) Methylglyoxal modification of protein: chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 274: 18492-18502
41. Qian M, Liu M and Eaton JW (1998) Transition metals bind to glycated proteins forming redox active 'glycochelates': implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun 250: 385-389
42. Rattan SI, Derventzi A and Clark BF (1992) Protein synthesis, posttranslational modifications, and aging. Ann NY Acad Sci 663: 48-62
43. Reckelhoff JF, Hennington BS, Kanji V et al. (1999) Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats. Am J Hypertens 12: 492-498
44. Reiser KM (1994) Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice. J Gerontol 49: B71-B79
45. Requena JR, Fu M-X, Ahmed MU et al. (1997) Quantitation of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 322: 317-325
46. Rodriguez-Garcia J, Requena JR and Rodriguez-Segade S (1998) Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin Chem 44: 250-255
47. Rosenfeld ME, Palinski W, Yla-Herttuala S et al. (1990) Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10: 336-349
48. 2-protein adducts in human plasma and vasculature. Chem Res Toxicol 10: 536-545
49. Sano H, Nagai R, Matsumoto K et al. (1999) Receptors for proteins modified by advanced glycation endproducts (AGE) - their functional role in atherosclerosis. Mech Ageing Dev 15: 333-346
50. Saxena AK, Saxena P, Wu X et al. (1999) Protein aging by carboxy-methylation of lysines generates sites for divalent metal and redox active copper binding: relevance to diseases of glycoxidative stress. Biochem Biophys Res Commun 260: 332-338
51. Sayre LM, Sha W, Xu G et al. (1996) Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem Res Toxicol 9: 1194-1201
52. Schmidt AM, Hori O, Cao R et al. (1996) RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 (Suppl 3): S77-S80
53. Sell DR and Monnier VM (1989) Structure elucidation of a senescence cross-link from human extracellular matrix: implication of pentoses in the aging process. J Biol Chem 264: 21597-21602
54. Sell DR and Monnier VM (1997) Age-related association of tail tendon break time with tissue pentosidine in DBA/2 vs. C57BL/6 mice: the effect of dietary restriction. J Gerontol 52: B277-284
55. Sell DR, Lane MA, Johnson WA et al. (1996) Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci USA 93: 485-490
56. Sharov VS, Ferrington DA, Squier TC et al. (1999) Diastereoselective reduction of protein-bound methionine sulfoxide by methionine sulfoxide reductase. FEBS Lett 455: 247-250
57. Shipanova IN, Glomb MA and Nagaraj RH (1997) Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 344: 29-36
58. Smith MA, Harris PL, Sayre LM et al. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94: 9866-9888
59. Song X, Bao M, Li D et al. (1999) Advanced glycation in D-galactose induced mouse aging model. Mech Ageing Dev 108: 239-251
60. Stadtman ER and Berlett BS (1998) Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 30: 225-243
61. Stevens A (1998) The contribution of glycation to cataract formation in diabetes. J Am Optom Assoc 69: 519-530
62. Sugiyama S, Miyata T, Inagi R et al. (1998) Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis. Int J Mol Med 2: 561-565
63. Suzuki S, Hinokio Y, Komatu K et al. (1999) Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res Clin Pract 45: 161-168
64. Terman A and Brunk U (1998) Lipofuscin: mechanisms of formation and increase with age. APMIS 106: 265-276
65. Tessier F, Obrenovich M and Monnier VM (1999) Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis. J Biol Chem 274: 20796-20804
66. Thorpe SR and Baynes JW (1996) Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs & Aging 9: 69-77
67. Tsai L, Szweda PA, Vinogradova O et al. (1998) Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proc Natl Acad Sci USA 95: 7975-7980
68. ∈-(2-propenal)lysine in proteins. Arch Biochem Biophys 346: 45-52
69. Uchida K, Kanematsu M, Sakai K et al. (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 95: 4882-4887
70. Weindruch R and Walford RL (1988) The Retardation of Aging and Disease by Dietary Restriction. Charles C Thomas, Springfield, Illinois
71. Wells-Knecht MC, Lyons TJ, McCance DR et al. (1997) Age-dependent accumulation of ortho-tyrosine and methionine sulfoxide in human skin collagen is not increased in diabetes: evidence against a generalized increase in oxidative stress in diabetes. J Clin Invest 100: 839-846
72. Wright HT (1991) Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. Crit Rev Biochem Mol Biol 26: 1-52
73. Yan LJ and Sohal RS (1998) Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci USA 95: 12896-12901
74. Yan LJ, Levine RL and Sohal RS (1997) Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci USA 94: 11168-11172
75. Yim HS, Kang SO, Hah YC et al. (1995) Free radicals generated during the glycation reaction of amino acids by methylglyoxal. A model study of protein-cross-linked free radicals. J Biol Chem 270: 28228-28233
76. Yin D (1996) Biochemical basis of lipofuscin, ceroid and age pigment-like fluorophores. Free Radic Biol Med 21: 871-888